[go: up one dir, main page]

DK30092A - Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler - Google Patents

Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler Download PDF

Info

Publication number
DK30092A
DK30092A DK030092A DK30092A DK30092A DK 30092 A DK30092 A DK 30092A DK 030092 A DK030092 A DK 030092A DK 30092 A DK30092 A DK 30092A DK 30092 A DK30092 A DK 30092A
Authority
DK
Denmark
Prior art keywords
patient
lollipop
methods
aedosis
lipofile
Prior art date
Application number
DK030092A
Other languages
English (en)
Other versions
DK175773B1 (da
DK30092D0 (da
Inventor
Theodore H Stanley
Brian Hague
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Publication of DK30092D0 publication Critical patent/DK30092D0/da
Publication of DK30092A publication Critical patent/DK30092A/da
Application granted granted Critical
Publication of DK175773B1 publication Critical patent/DK175773B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK199200300A 1989-09-05 1992-03-05 Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler DK175773B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
US8903801 1989-09-05

Publications (3)

Publication Number Publication Date
DK30092D0 DK30092D0 (da) 1992-03-05
DK30092A true DK30092A (da) 1992-05-05
DK175773B1 DK175773B1 (da) 2005-02-14

Family

ID=22215208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199200300A DK175773B1 (da) 1989-09-05 1992-03-05 Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler

Country Status (8)

Country Link
EP (1) EP0493380B1 (da)
JP (1) JP2758985B2 (da)
AT (1) ATE159658T1 (da)
AU (2) AU645966B2 (da)
DE (1) DE68928415T2 (da)
DK (1) DK175773B1 (da)
NO (2) NO920854L (da)
WO (1) WO1991003233A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (da) * 1977-08-05 1981-07-15 Battelle Memorial Institute
ATE300937T1 (de) * 1995-05-11 2005-08-15 Univ Utah Res Found Tabakersatz
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
WO2007090113A2 (en) * 2006-02-01 2007-08-09 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
PL3200764T3 (pl) * 2014-10-01 2020-12-28 Oxytone Bioscience B.V. Rozpadająca się w jamie ustnej stała farmaceutyczna jednostka dawkowania zawierająca substancję kontrolującą poród
ES2690140T3 (es) 2014-10-01 2018-11-19 Oxytone Bioscience B.V. Unidad de dosificación farmacéutica sólida de desintegración oral que contiene una sustancia de control del parto
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN113993523A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗抑郁症和其他各种病症

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Also Published As

Publication number Publication date
DK175773B1 (da) 2005-02-14
EP0493380A1 (en) 1992-07-08
AU6069794A (en) 1994-06-23
ATE159658T1 (de) 1997-11-15
EP0493380B1 (en) 1997-10-29
NO920854L (no) 1992-04-27
JPH05501854A (ja) 1993-04-08
DE68928415D1 (de) 1997-12-04
JP2758985B2 (ja) 1998-05-28
EP0493380A4 (en) 1992-10-07
WO1991003233A1 (en) 1991-03-21
AU5035290A (en) 1991-04-08
AU645966B2 (en) 1994-02-03
NO920854D0 (no) 1992-03-04
DK30092D0 (da) 1992-03-05
NO920855L (no) 1992-04-10
NO920855D0 (no) 1992-03-04
DE68928415T2 (de) 1998-02-26

Similar Documents

Publication Publication Date Title
Bowles et al. Evaluation of new gingival retraction agents
Kennedy et al. Intravenous regional analgesia: an appraisal
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
NO924209D0 (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
ATE92762T1 (de) Medikamente.
DK30092A (da) Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
Bloom et al. Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: A double-blind cross-over study with methyldopa.
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
Humphrey et al. Aspects of fibrocystic disease of the breast. Treatment with danazol
Sugai et al. Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man
RU94018748A (ru) Лекарственный сбор для лечения больных с нарушениями сердечного ритма
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
Reynolds et al. Circulatory versus respiratory deaths from pentothal sodium
CN2233753Y (zh) 护心袋
RU97110054A (ru) Способ лечения синдрома "диабетическая стопа"
CN2224631Y (zh) 药物保健袋
Pinterova et al. The effect of bopindolol on lipids and platelet aggregation
KR100259176B1 (ko) 엘-무스콘의 의약용도
Aman et al. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus
Samuels et al. Regional anesthesia for the emergency department physician

Legal Events

Date Code Title Description
PUP Patent expired